Xcout Intel
Deep Genomics
Deep Genomics is a biotechnology research company that collaborates across disciplines to solve complex molecular design challenges. The company's corporate headquarters are located in Toronto, Ontario, Canada, a hub for innovation.
Subscribe to see Deep Genomics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Deep Genomics at a glance
Deep Genomics is a biotech company. Xcout tracks 9 named people at Deep Genomics, including Brian O'Callaghan (Chief Executive Officer). Xcout recorded 5 job postings from Deep Genomics in the last 90 days.
Deep Genomics leadership
- Brian O'CallaghanChief Executive Officer
- Tom MastersonChief Operating Officer
- David JohnstonChief Financial Officer
- Clive BertramChief Business Officer
- Greg HoffmanChief Scientific Officer
- Brendan FreyChief Innovation Officer and Founder
3 more named people on record for Deep Genomics, with roles, board committees and tenure — see the full roster →
Hiring at Deep Genomics
Xcout recorded 5 job postings from Deep Genomics in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Deep Genomics's hiring signals →
Tech stack
Deep Genomics competitors
A few of Deep Genomics's closest competitors — see the full list of competitors and alternatives →
Verge Genomics develops a proprietary AI and machine learning platform utilizing human brain data to transform neuroscience drug discovery and precision neurology. The company provides foundation models and analytical tools to pharmaceutical and biotechnology developers for target discovery, biomarker identification, and clinical trial patient stratification.
GATC Health Corp. is a biotechnology company that uses artificial intelligence, genomics, and toxicology data to discover and develop therapeutics and predict drug safety. Its work is aimed at pharmaceutical and biotechnology partners as well as patients needing treatments for serious diseases.
9Bio Therapeutics is a biotechnology company that combines biology, structural engineering, and artificial intelligence to pioneer next-generation biologics for advanced cancers. The company is headquartered in Quebec, Canada.
Dyno Therapeutics is a biotechnology research company headquartered in Watertown, Massachusetts, specializing in gene therapy delivery solutions using artificial intelligence.
Atomic AI is a biotechnology research company specializing in RNA drug discovery utilizing atomic precision. Headquartered in San Francisco, California, the company combines machine learning and biology to develop advanced therapeutics.
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Get Deep Genomics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Deep Genomics in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access